Literature DB >> 27978582

A Comparison of Vascularized Free Fibular Flaps and Nonvascularized Fibular Grafts for Reconstruction of Long Bone Defects after Tumor Resection.

Emmanuel Pantaleon Estrella1, Edward H M Wang2.   

Abstract

Background The use of the fibula autograft has been a reliable method in the reconstruction of long bone defects after tumor resection. The objective of this study was to report the outcomes fibular grafting in terms of graft union, functional score, complications, and oncologic outcome. Methods A retrospective review of patients with fibular grafting after tumor resection was done from January 1, 1993 to December 31, 2013. The primary outcome was graft union and the revised musculoskeletal tumor society scoring system (MSTS score). The secondary outcomes were oncologic outcomes, complications, and the factors associated with graft union. Results A total of 52 patients with a mean follow-up of 42 months (SD, 33; range, 12-132 months) were included. The overall union for all fibular grafts was 37 of 52. The use of vascularized free fibula flaps had a higher union rate compared with nonvascularized fibula grafts. The use of a vascularized free fibular flap was four times likely to unite (95% CI 1.1-12.8, p = 0.039) compared with nonvascularized fibular grafts. The mean MSTS score in 36 patients was 82.5 (SD, 12.9) at 35 months from surgery (SD, 30). A total of 39 complications were present in 29 patients. On final follow-up, 45 of 52 patients were alive, six patients had died of disease and one died of other causes. Conclusion A higher union rate was achieved using vascularized free fibular flaps compared with nonvascularized fibular grafts for long bone reconstruction after tumor resection. There was no difference in terms of MSTS score between the two types of grafts. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27978582     DOI: 10.1055/s-0036-1594299

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  8 in total

1.  [Imaging study and clinical application of peroneal perforating chimeric tissue flap].

Authors:  Ziyang Zhang; Wenhu Jin; Hui Quan; Jianping Qi; Zairong Wei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-04-15

Review 2.  Recent developments in biomaterials for long-bone segmental defect reconstruction: A narrative overview.

Authors:  Meng Zhang; Jukka P Matinlinna; James K H Tsoi; Wenlong Liu; Xu Cui; William W Lu; Haobo Pan
Journal:  J Orthop Translat       Date:  2019-10-08       Impact factor: 5.191

3.  Lengthening of free fibular grafts for reconstruction of the residual leg length discrepancy.

Authors:  Xianghong Zhang; Tingting Zhang; Tang Liu; Zhihong Li; Xiangsheng Zhang
Journal:  BMC Musculoskelet Disord       Date:  2019-02-08       Impact factor: 2.362

4.  Reconstruction of mandibular defects using vascularized fibular osteomyocutaneous flap combined with nonvascularized fibular flap.

Authors:  W Wang; J Zhu; B Xu; B Xia; Y Liu; S Shao
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2019-09-01

Review 5.  Intercalary frozen autografts for reconstruction of bone defects following meta-/diaphyseal tumor resection at the extremities.

Authors:  Jingyan Yang; Wenze Li; Rongjie Feng; Dong Li
Journal:  BMC Musculoskelet Disord       Date:  2022-09-30       Impact factor: 2.562

6.  Long-term follow-up of fibular graft for the reconstruction of bone defects.

Authors:  Siyi Liu; Shengxiang Tao; Jinhai Tan; Xiang Hu; Huiyi Liu; Zonghuan Li
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Jaw reconstruction with vascularized fibular flap: The 11-year experience among 104 patients.

Authors:  Shengjie Shao; Weihong Wang; Biao Xu; Yu Liu; Zhe Zhang
Journal:  World J Surg Oncol       Date:  2020-02-29       Impact factor: 2.754

Review 8.  Strategies for large bone defect reconstruction after trauma, infections or tumour excision: a comprehensive review of the literature.

Authors:  Filippo Migliorini; Gerardo La Padula; Ernesto Torsiello; Filippo Spiezia; Francesco Oliva; Nicola Maffulli
Journal:  Eur J Med Res       Date:  2021-10-02       Impact factor: 2.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.